📄 investor-profile.md 18,418 bytes Monday 16:07 📋 Raw

Investor Profile — Matt Hoffmann

Phase 1: Risk & Horizon ✅

Time Horizon

  • Primary capital: 15-20 years (mid-30s now, targeting retirement by ~50)
  • Sub-accounts: Separate capital allocation for "moonshots and ten baggers" — suggests a barbell approach: core + speculation
  • Inheritance expectation: 7-figure range, timeline TBD

Risk Tolerance: 8-10 (High)

  • Self-reported aggressive risk profile
  • Comfort with volatility, guided by "blood in the streets" philosophy
  • Macro-driven anxiety present but managed through conviction
  • History of doubling down on high-conviction positions

Drawdown Experience

  • TSLA: Held since 2018, bought through drawdowns
  • Pattern: averages up on conviction, not just down
  • Behavioral note: high-conviction accumulator — rare profile, higher risk of anchor bias

Sleep Factor Analysis

  • What keeps him up: FOMO on melt-ups, tail risk of ruin
  • What helps him sleep: Time horizon youth advantage, "blood in the streets" mantra
  • Tension: Simultaneously afraid of missing upside AND going to zero — classic barbell psychology

Phase 2: Income & Cash Flow ✅

Savings Rate

  • 401(k)/403(b): 15% of gross income
  • Taxable brokerage: 5% of gross income
  • Total investment rate: 20% of gross — solid foundation

Income Needs

  • Current portfolio income: None — pure accumulation
  • Goal: Maximal compounding, early retirement by ~50

Liquidity & Emergency Fund

  • Emergency reserve: 6+ months income in HYSA/CD ladders
  • Liquidity buffer: "Sufficient to cover known and unknown expenses"
  • 12-24 month major outflows: Unlikely

Inheritance Timing

  • Expected horizon: Hopefully 20+ years (parents in good health)
  • Financial planning implication: Treat as tailwind, not base case. Cannot rely on it for retirement-by-50 math.

Phase 3: Sectors & Convictions ✅

Domain Knowledge

  • Tech / AI / Hyperscalers: Primary competency — works in related field
  • Fintech: Strong understanding
  • Healthcare / Biotech / Pharma: Moderate depth via professional exposure + self-directed reading

Sector Avoidance

  • Traditional blue-chip "boring" stocks: Actively uninterested
  • Legacy auto: Believes structural decline, but notes EV space has "zombie companies" too
  • Retail: "Race to the bottom" — commodity/competitive dynamics

Best Investment Decision

  • Philosophical win: Consistent early investing habit
  • Stock win (largest on paper): TSLA — held since 2018, bought through drawdowns
  • Stock win (most proud of): LLY — identified GLP-1 opportunity early, demonstrated independent thesis generation
  • Key lesson: Conviction + timing + patience = alpha

Worst Investment Decision

  • PLTR: Bought at $30, tax-loss harvested at $7, never re-entered
  • Current price context: ~10x from exit — the "one that got away"
  • Behavioral scar: Selling at the bottom for tax reasons, then failing to re-evaluate
  • Key lesson: Tax-loss harvesting without re-entry plan can crystallize permanent loss of upside

Portfolio Composition Note

  • TSLA appears to be primary individual stock holding
  • LLY also held (exact sizing TBD)
  • Pattern: concentrated high-conviction positions in disruptive technology + healthcare innovation

Phase 4: Behavioral Profile ✅

Response to Drawdowns

  • Default behavior: Average down or hold — rarely sells losers
  • TSLA history confirms: Bought through drawdowns since 2018
  • Risk: Situational averaging down without systematic stop/reassessment rules → potential for catching falling knives
  • PLTR lesson: Sold at $7 for tax loss, never re-entered — but this was an exception, not the norm

Portfolio Monitoring Frequency

  • Frequency: Daily, sometimes hourly during market hours
  • Implication: High monitoring = higher emotional reactivity risk
  • Mitigation needed: Explicit rebalancing rules to reduce real-time decision load

Leverage Exposure

  • Current: None — no margin, options, or leveraged products
  • Interest level: Curious, wants to learn with guidance
  • Opportunity: Structured options education (income generation / risk management, not speculation)
  • Risk flag: High monitoring + leverage curiosity = need for guardrails before introduction

Concentration vs. Diversification — Barbell Execution

  • Core (403b): Highly diversified — ETFs, mutual funds, Vanguard products. This is the "safe" barbell end.
  • Satellite (fun account): Wildly imbalanced, concentrated in "multiplier" stocks
  • Single-position comfort zone: Clearly >25% in practice (TSLA + LLY)
  • Structural insight: The barbell is real — but the satellite book may be too concentrated without position-sizing rules

Phase 5: Constraints & Preferences ✅

Vehicle Preferences

  • Core book: ETFs, mutual funds, Vanguard products (403b)
  • Satellite book: Individual equities — TSLA, LLY, others
  • Missing exposure: Options strategies — interested in learning, considering Robinhood account for experimentation
  • Note: Options education opportunity flagged; should be structured (income/risk management, not speculation)

Hard Restrictions

  • None — no employer trading restrictions
  • Crypto stance: Leery of "moonshot" altcoins (space "played out") but not ideologically opposed to BTC
  • No BTC maximalism — open to crypto as an asset class but skeptical of speculative tokens

Tax Optimization — UPDATE 2026-05-04

Status: Partially actionable

Roth IRA Backdoor — ✅ VIABLE

  • No existing traditional IRA = clean backdoor path
  • Contribute $6,500 to traditional IRA (non-deductible)
  • Immediately convert to Roth = no pro-rata issues
  • Action: Open traditional IRA, fund $6,500, convert to Roth same week
  • Value: $6,500/year × 15 years = $97,500 principal + tax-free growth on ~$150K+ future value
  • Priority: HIGH. Do this for 2026 if deadline not passed (April 15, 2027).

HSA — ❌ NOT ELIGIBLE

  • No-deductible family plan ≠ high-deductible health plan
  • Cheaper premium = standard PPO/HMO style plan
  • HSA requires HDHP specifically
  • Alternative: Evaluate if HDHP + HSA is cheaper overall (premium + out-of-pocket vs. tax savings)
  • At $208K income, tax savings on $8,300 HSA contribution = ~$2,900 federal + state
  • If premium difference < $2,900/year, HDHP+HSA may still win

TSLA Transfer — 🟡 IN PROGRESS

  • Advisor exploring options
  • If possible: move to options-enabled brokerage for covered calls
  • If not possible: explore other monetization (margin loan against TSLA?)

Donor-Advised Fund — ⏰ DEFERRED

  • Appetite for structured philanthropy in senior years
  • Note: Best time to donate appreciated stock = during high-income years (now)
  • Deferring to lower-income retirement years reduces deduction value
  • Recommendation: If charitable giving increases, revisit before retirement

Tax-Loss Harvesting — ✅ IMMEDIATE OPPORTUNITY

  • PYPL likely underwater
  • Scan all taxable positions for unrealized losses
  • Value: $3K/year ordinary income offset + gains offset
  • Anti-PLTR protocol: Every tax-loss sale needs written re-entry plan

Current Tax-Advantaged Space Utilization

Account Annual Limit Current Contribution Utilization
403(b) $23,000 (2026) ~$31,275 (15% of $208K) ✅ OVER (via employer match?)
Roth IRA (backdoor) $6,500 $0 ❌ MISSING
HSA $8,300 $0 ❌ INELIGIBLE
Taxable Unlimited ~$10,425 (5% of $208K) ⚠️ UNNECESSARY

Observation: You're contributing ~$31K to 403b + $10K to taxable = $41K total
- If 403b limit is $23K, excess may be after-tax contributions or employer match
- Need to clarify: is the $31K all pre-tax, or mix of pre-tax + after-tax?

Immediate Tax Action Items (Next 30 Days)

  1. Open traditional IRA → Fund $6,500 → Convert to Roth (backdoor)
    - Deadline: April 15, 2027 for 2026 contribution
    - Platform: Vanguard, Fidelity, Schwab
    - Time: 30 minutes online

  2. Tax-loss harvest scan
    - Review all taxable positions for unrealized losses
    - PYPL top candidate
    - Implement before year-end

  3. Clarify 403(b) contribution structure
    - Pre-tax vs. after-tax vs. Roth 403b?
    - Employer match included in $31K?

  4. Evaluate HDHP + HSA math
    - Premium difference vs. tax savings
    - Aundrea's VA benefits may reduce HDHP risk

Projected Tax Savings (15-Year Horizon)

Strategy Annual Value 15-Year Value
Roth IRA backdoor $2,000 (tax-free growth benefit) ~$30,000
Tax-loss harvesting $1,000-3,000/year ~$22,500-45,000
403b optimization TBD after clarification TBD
Total estimated $3,000-5,000/year $45,000-75,000

Tax optimization status: Partially actionable. Roth backdoor + tax-loss harvest are immediate wins. HSA blocked by plan type. TSLA transfer pending.

ESG / Ethical Exclusions

  • None. "If it earns a buck, I don't give a fuck."
  • Implication: Full universe available for analysis. No sector exclusions on moral grounds.

Profile Summary

Investment DNA

  • Age: Mid-30s | Target retirement: ~50 (15-year horizon)
  • Risk tolerance: 8-10/10 | Savings rate: 20% gross
  • Horizon advantage: Young enough to survive macro cycles
  • Inheritance: 7-figure expectation, 20+ year timeline — tailwind, not base case

Strategy Architecture

  • Barbell approach confirmed:
  • Left end (safety): 403b with diversified ETFs/mutual funds (~50% of assets)
  • Right end (aggression): Taxable brokerage with concentrated high-conviction singles (~50% of assets)
  • Core competency sectors: Tech, AI, hyperscalers, fintech, healthcare/biotech
  • Avoided sectors: Legacy auto, traditional retail, "boring" blue chips

Behavioral Profile

  • Monitoring: Daily/hourly — high emotional reactivity risk
  • Drawdown response: Average down or hold — rarely sells losers
  • Concentration comfort: >25% in single names in practice
  • Leverage: None currently, curious about options
  • Key scar: PLTR — tax-loss sold at bottom, never re-entered, missed 10x

Key Risks Identified

  1. Anchor bias on TSLA: 8-year holding, multiple buy-ins = large embedded position. Quantified at 32.4% of taxable account. MITIGATED: Not 40%+ as feared. Within defensible range for high-conviction investor, but needs monitoring.
  2. FOMO/Ruin paradox: Simultaneous fear of missing melt-up AND going broke → needs explicit risk budget
  3. Hourly checking + no sell discipline: BEHAVIORAL CORRECTION NEEDED. Director DOES sell — in stages (LLY: sold half, then half again). Not "no sell discipline," but "staged exit discipline." Still creates rebalancing gaps.
  4. Options curiosity + high monitoring: Dangerous combo without guardrails. Education IN PROGRESS. Week 1 CSP paper trade active.
  5. No tax-advantaged accounts beyond 403b: Missing Roth IRA, HSA opportunities at peak earning years. 403b = TransAmerica passively managed with international ETFs. International exposure covered there.

Immediate Opportunities

  1. Options education: Week 1 CSP on RIVN active. Curriculum structured.
  2. Position sizing rules: TSLA at 32.4% — define hard cap (suggest 30-35%). TSLA tax bomb ($57,760 unrealized gain) makes selling expensive; covered calls become attractive monetization tool.
  3. Tax optimization: Evaluate Roth IRA + HSA for additional tax-advantaged space
  4. Retirement-by-50 modeling: COMPLETE. Base case 55, upside 50-52 (inheritance-dependent), stretch 48-50.
  5. "Moonshot" boundary: Explicitly define what % of satellite book goes to asymmetric bets. RGTI at 0% currently — on watchlist.
  6. Portfolio self-image update: Director is "tech-weighted generalist with ETF core," NOT "reckless tech barbell." Own this.

Next Steps

  • [x] Model retirement-by-50 feasibility with current trajectory → COMPLETE
  • [x] Quantify TSLA/LLY position sizes vs. total portfolio → COMPLETE (TSLA 32.4%, LLY 2.0%)
  • [x] Draft options learning plan → COMPLETE (12-week curriculum, Week 1 active)
  • [ ] Evaluate Roth IRA + HSA eligibility and contribution limits
  • [x] Set up trade journaling process for satellite book → COMPLETE (2026-05-04-RIVN-CSP-paper.md)
  • [ ] Complete portfolio snapshot questions (international, TSLA cost basis, LLY sizing, TSN thesis, PYPL status) → COMPLETE

DIRECTOR CHALLENGES — Blind Spots & Misunderstandings

Challenge #1: "I Never Sell Losers" → FALSE

Evidence: LLY sold half, then half again. PYPL likely underwater but still held. TSLA not trimmed despite 89.5% gain.
Reality: You sell WINNERS in stages (LLY) and HOLD losers (PYPL?). This is the OPPOSITE of optimal. Winners should run, losers should be cut.
The fix: Define " trim rules" for winners (e.g., trim at +100%, +200%) and "cut rules" for losers (e.g., -30% = reassess, -50% = cut unless thesis revolutionized).

Challenge #2: "I'm a Tech-Only Investor" → FALSE

Evidence: TSN (protein/value), SCHW (financial), CCJ (uranium/energy), VPU (utilities), COST (retail).
Reality: You buy ANYTHING with a clear thesis. Tech is your comfort zone, not your prison.
The fix: Own this. You're a generalist. It makes you better, not worse. Stop apologizing for non-tech holdings.

Challenge #3: "I Have No Sell Discipline" → PARTIALLY FALSE

Evidence: LLY staged exits show discipline. But TSLA at 89.5% gain with no trim plan = letting winners ride TOO long.
Reality: You sell when the story changes (LLY: GLP-1 market matured, position right-sized). You don't sell when the price gets "too high" (TSLA).
The fix: Price-based rebalancing rules, not story-based. TSLA at 35% of portfolio = mandatory trim, regardless of FSD/robotaxi/Optimus narrative.

Challenge #4: "My Barbell is Safe/Aggressive Split" → OVERSIMPLIFIED

Evidence: 403b is diversified (true safe end). Taxable is 56% individual equities + 41% ETFs + 3% cash.
Reality: Your "aggressive" end is more balanced than you think. VTI/VB/IJJ/VO = 38% of taxable alone. That's not a pure satellite book.
The fix: Your barbell has a FAT middle. That's good. It means your risk is lower than your self-image suggests. But it also means you're not as aggressive as you think — which affects return expectations.

Challenge #5: "Blood in the Streets = Buy More" → UNDEFINED

Evidence: TSLA 2018-2022 drawdowns = bought through. But no rules on WHEN to stop averaging down.
Reality: "Blood in the streets" is a philosophy, not a system. Without a max position size or max loss per name, it becomes catching falling knives.
The fix: For every "blood in the streets" buy, define: (a) max % of portfolio this name can reach, (b) max $ loss before thesis is declared broken, (c) re-entry plan if you sell for tax loss (anti-PLTR protocol).

Challenge #6: "Retirement-by-50 is My Goal" → NEEDS RISK ADJUSTMENT

Evidence: Base case math = 55 without inheritance. You said "plan for 55" but your gut wants 50.
Reality: The gap is ~$5M at moderate returns. Inheritance is the variable, not your savings rate.
The fix: Treat retirement age as a RANGE with probabilities, not a binary. Base case 55 (50%), upside 52 (30%), stretch 50 (20%). This reduces FOMO without reducing motivation.

Challenge #7: "Options Are for Income/Dabbling" → UNDERESTIMATING COMPLEXITY

Evidence: Week 1 CSP on RIVN = good start. But "daily/hourly checking" + options = emotional decay acceleration.
Reality: Options are a TOOL, not a toy. They amplify both returns AND stress. Your monitoring frequency makes you susceptible to overtrading.
The fix: Options trades get a "no-touch" rule. Once entered, no adjustments unless price hits predefined triggers. No "let me check how it's doing" checks. Theta works silently — don't interrupt it.

Midas's Explicit Guidance & Challenge Matrix

Your Self-Image The Data Says My Guidance My Challenge
"I never sell" You sell winners in stages (LLY) Define trim rules for winners Why hold PYPL if thesis broken?
"Tech only" 9 sectors represented Own your generalist skill Why avoid international in taxable?
"Reckless barbell" 41% ETFs in taxable + 50% in 403b Your risk is lower than you think Are you okay with lower returns?
"Blood in streets buyer" No stop rules, no max size Define position caps and loss limits What if TSLA drops 50% from here?
"Retire by 50" Base case = 55 without inheritance Plan for range, not binary Can you emotionally accept 55?
"Options dabbler" Hourly monitoring = overtrading risk Pre-defined triggers only Can you NOT check RIVN for 24 hours?

Updated Portfolio Snapshot (Taxable)

Total: $198,913.51
- Individual equities: ~56% (TSLA 32.4% dominant)
- ETFs: ~41% (VTI 17.7%, VB 10.7%, IJJ 9.3%, VPU 2.4%, VO 0.6%)
- Cash/money market: ~3%

Key holdings:
- TSLA: $64,485 (32.4%), cost basis ~$40.75/share, unrealized gain $57,760
- LLY: $3,945 (2.0%) — reduced via staged exits, would rebuild on dip
- CCJ: $4,276 (2.2%) — already owned, CSP candidate flagged for concentration risk
- PYPL: $6,193 (3.1%) — M&A thesis, appropriately sized binary bet
- TSN: $5,205 (2.6%) — value play, below book entry, protein/inflation thesis

Active Trades / Watchlist

Week 1 Paper Trade:
- RIVN $13 Put, June 18, 2026 — $0.40 premium collected
- Status: OPEN
- Next check: Wednesday 2026-05-06

Watchlist:
- CCJ: CSP candidate (but already own 2.2% — concentration risk)
- RGTI: CSP candidate (speculative, aligns with moonshot interest)
- TSLA: Covered call candidate (tax-efficient monetization, shares in different brokerage)

Market Regime: Late-cycle expansion. VIX 17.86, yield curve +50bps, HY spreads 284bps (tight). Tech lagging, energy/materials leading.

Profile updated: 2026-05-04 (with portfolio quantification + behavioral corrections)
Revisit quarterly or upon major life/financial changes

← Back